Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Identification of New Biomarkers of Banana and Tomato Intake (BioBanaTom)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03581955
Recruitment Status : Completed
First Posted : July 10, 2018
Last Update Posted : July 16, 2018
Sponsor:
Collaborator:
National Research Agency, France
Information provided by (Responsible Party):
Claudine MANACH, Institut National de la Recherche Agronomique

Brief Summary:
The intake of fruits and vegetables has been associated to a lower risk of developing metabolic diseases and cancer. The intake of tomato has been proposed to decrease the risk of prostate cancer while the high content of pro-vitamine A carotenes in banana have shown to alleviate Vitamin A deficiency in different countries. Interestingly in spite of their popularity, there are no biomarkers of banana intake reported in the literature while lycopene is the most frequently used metabolite to indicate tomato consumption however, its limited specificity and between-subjects variation sets doubt of its accuracy. Therefore, the identification of novel biomarkers for both banana and tomato is of great value. Untargeted metabolomics, allows a holistic analysis of the food metabolome allowing a deeper inquiry in the metabolism of different compounds and the recognition of patterns and individual differences that may lead to new hypothesis and further research. Therefore, the aim of the present study is to identify biomarkers of acute intake of banana and tomato using an untargeted approach on urine serum of 12 volunteers that participated in a crossover, randomized, controlled study. Volunteers consumed three different test foods: 1) 240g of banana, 2) 300g of tomato and 3) Fresubin 2kcal as control. Serum and urine samples were collected in kinetics over 24h and processed to be analyzed using LC-QTof analysis. The metabolomics profiles are compared using univariate (ANOVA) and multivariate statistical methods (PCA, PLSDA). The identification of discriminant compounds was performed by tandem mass fragmentation with a high-resolution LTQ-Orbitrab Mass spectrometer and by an extensive inquiry of different online databases.

Condition or disease Intervention/treatment Phase
Biomarkers Food Intake Other: Banana Cavendish Other: Tomato Other: Fresubin ® 2kcal fiber neutral flavor Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: The present project is a randomized, controlled, crossover study with 12 subjects. A cross-over design has been selected as each subject can serve as his/her own control thereby minimizing variations. The intervention order was randomized. The study design does not allow blinding as intervention is the ingestion of different foods.In this study, we assessed the metabolomic profiles of human biofluids after consumption of two different foods: banana (240g peeled fruit) and tomato (300g fresh fruit) in order to identify novel biomarkers for each food. As a control diet, a high energy high protein drink, Fresubin ® 2kcal fiber (Fresinius kabi) was used. The study comprised three dietary interventions of 4 days each and a wash-out period no shorter than 3 days.
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Identification of New Biomarkers of Banana and Tomato Intake
Actual Study Start Date : March 26, 2016
Actual Primary Completion Date : May 19, 2016
Actual Study Completion Date : June 16, 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Banana Cavendish
240g of fruit plus 150ml of Fresubin ® 2kcal fiber neutral flavor
Other: Banana Cavendish
240g of fruit plus 150ml of control drink (Fresubin ® 2kcal fiber neutral flavor)
Other Name: Test Food

Experimental: Control drink
250ml of Fresubin ® 2kcal fiber neutral flavor
Other: Fresubin ® 2kcal fiber neutral flavor
250 ml Fresubin ® 2kcal fiber neutral flavor
Other Name: Control

Experimental: Tomato
300g of tomato plus of Fresubin ® 2kcal fiber neutral flavor plus 12g of refined sunflower oil.
Other: Tomato
300g of raw tomato ("coeur de boeuf") with refined sunflower oil (12g) and 150ml of control drink (Fresubin ® 2kcal fiber neutral flavor).
Other Name: Test Food




Primary Outcome Measures :
  1. Changes in metabolite profiles present in blood serum and urine before the dietary intervention (t=0) and in kinetics over 24 hours. [ Time Frame: 0-24 hours ]
    Metabolite profiles analyzed using a non-targeted metabolomics approach with a UPLC-MS platform. Blood serum samples collected at time 0, 1 hour, 2 hours, 4 hours, 6 hours and 24 hours. Urine fractions collected at 0-1 hours, 1-2 hours, 2-4 hours, 4-6 hours, 6-12 hours, 12-24 hours. Identification of biomarkers of acute intake of the foods of interest through the comparison of metabolomes after either single dose of tomato, banana or control drink.


Secondary Outcome Measures :
  1. Collection of pools of urine and serum samples after acute intake of tomato or banana to be used as analytical standards or for the identification of specific metabolites of banana or tomato components. [ Time Frame: 0-24 hours ]
    The collection of pools of biofluids that result from this study may be shared with the scientific community through the FoodComEx library in order to be used as an analytical standard or for the identification of metabolites that are specific of banana or tomato intake.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy males and females
  • Aged 18- 40 years
  • BMI >18.5 and < 30 kg/m2
  • Willing/able to consume all test foods (tomato, banana, Fresubin drink) and the standardized meals (rice and chicken)

Exclusion Criteria:

  • Smokers
  • Diagnosed health condition (chronic or infectious disease)
  • Taking nutritional supplements (e.g. vitamins, minerals) several times a week.
  • Taking medication (oral contraceptive pill is allowed).
  • Pregnant, lactating.
  • Antibiotics treatment within 3 months prior to intervention.
  • Vegetarians, as standardized meals will contain meat.
  • Not willing to follow nutritional restrictions, including drinking alcohol during study days
  • Not willing/able to give informed consent or to sign informed consent.
  • Not affiliated to National Health Insurance.
  • Being in exclusion on the National Volunteers Data file or refusing to be registered on the National Volunteers Data file.
  • Currently participating or who having got 4500€ in this year to have participated in another clinical trial.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03581955


Locations
Layout table for location information
France
INRA
Clermont-Ferrand, Rhône-Alpes-Auvergne, France, 63122
Sponsors and Collaborators
Claudine MANACH
National Research Agency, France
Investigators
Layout table for investigator information
Principal Investigator: Claudine Manach, Researcher Institut National de la Recherche Agronomique
  Study Documents (Full-Text)

Documents provided by Claudine MANACH, Institut National de la Recherche Agronomique:
Study Protocol  [PDF] June 25, 2018
Statistical Analysis Plan  [PDF] June 25, 2018

Publications:
Peralta I, Spooner DM. Genetic Improvement of Solanaceous Crops Volume 2: Tomato. CRC Press; 2006. https://books.google.com/books?hl=en&lr=&id=1m7RBQAAQBAJ&pgis=1. Accessed December 18, 2015
Manach C., Brennan L, Drasgted L.O. Metabolomics to evaluate food intake and utilization in nutritional epidemiology. In: Metabolomics as a Tool in Nutritional Research, Woodhead publishing 2015. pp.167-196

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Claudine MANACH, Principal Investigator, Institut National de la Recherche Agronomique
ClinicalTrials.gov Identifier: NCT03581955    
Other Study ID Numbers: 2016-A00153-48
First Posted: July 10, 2018    Key Record Dates
Last Update Posted: July 16, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Claudine MANACH, Institut National de la Recherche Agronomique:
biomarkers
diet
banana
tomato
urine
plasma
intake
exposure
metabolomics